Golden State Equity Partners’s Thermo Fisher Scientific TMO Stock Holding History

Golden State Equity Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.61M	Buy	5,319 +2,685	+102%	+$1.46M	0.2%	118
2025 Q4	$1.53M	Buy	2,634 +37	+1%	+$20.9K	0.25%	84
2025 Q3	$1.26M	Sell	2,597 -421	-14%	-$196K	0.21%	116
2025 Q2	$1.22M	Buy	3,018 +2,047	+211%	+$856K	0.23%	103
2025 Q1	$483K	Buy	971 +22	+2%	+$11.9K	0.1%	248
2024 Q4	$494K	Buy	949 +367	+63%	+$202K	0.09%	238
2024 Q3	$360K	Sell	582 -37	-6%	-$21.9K	0.19%	129
2024 Q2	$342K	Buy	+619	New	+$355K	0.07%	297
2023 Q4	$346K	Buy	+651	New	+$315K	0.08%	251
2023 Q3	–	Sell	-386	Closed	-$201K	–	354
2023 Q2	$201K	Buy	+386	New	+$208K	0.06%	347
2022 Q1	–	Sell	-952	Closed	-$635K	–	221
2021 Q4	$635K	Buy	+952	New	+$594K	0.32%	77

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Golden State Equity Partners's TMO Position: Q1 2026 in Review

Golden State Equity Partners increased its Thermo Fisher Scientific (TMO) stake by 102% in Q1 2026, buying an estimated $1.46M and bringing the position to 5,319 shares worth $2.61M. The position accounts for 0.2% of the portfolio, ranked #118.

Golden State Equity Partners first reported a position in TMO in Q4 2021 and has held it in 11 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Golden State Equity Partners held 5,319 shares of Thermo Fisher Scientific worth $2.61M as of Q1 2026.
Golden State Equity Partners bought 2,685 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.46M.
Thermo Fisher Scientific made up 0.2% of Golden State Equity Partners's portfolio in Q1 2026, its #118 holding.
Golden State Equity Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 11 quarters since.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.